Seventeenth Edition of CPHI & PMEC India to Showcase Pharma Progress

The 17th edition of CPHI & PMEC India, organized by Informa Markets in India, is set to take place from November 26-28, 2024, at the India Expo Centre in Greater Noida, Delhi-NCR.

Known as a comprehensive destination for innovative and cost-effective solutions, 17th edition of CPHI & PMEC expo will focus on modernization, sustainability, and technological advancements in India’s thriving pharmaceutical industry.

Growth Trajectory

India’s pharmaceutical industry is expanding rapidly. It is expected to reach $65 billion by the end of 2024, with projections doubling to $130 billion by 2030.

The CPHI & PMEC India Expo is a testament to this growth, gathering over 2,000 exhibitors and fostering connections between global and domestic stakeholders.

This year’s participants include industry leaders from around the world, with representatives from the USA, UAE, South Korea, Japan, Italy, and other countries.

Marketplace for Innovation

The expo will serve as a vital marketplace, bringing together pharmaceutical executives, buyers, hospital administrators, and government representatives.

Renowned exhibitors like Dr. Reddy’s Laboratories Ltd, Biocon Ltd, Glenmark Lifesciences Ltd, Morepen Laboratories Ltd, and Merck Life Science Pvt. Ltd. will be showcasing their latest developments in pharmaceuticals. These companies will present their innovations in pharmaceuticals.

PMEC exhibitors, including ACG, Accupack Engineering, and Ace Technologies, will present
cutting-edge equipment for pharmaceutical manufacturing, highlighting innovations in machinery and technology.

Industry Support

The event enjoys the support of key industry associations like CIPI, FOPE, IPEC India, and Pharmexcil. This reinforces its reputation as a premier gathering for the pharmaceutical industry.

Yogesh Mudras, Managing Director, Informa Markets in India stated, “India’s pharmaceutical sector, ranking third globally by production volume. It is a leader in delivering high-quality, affordable medicines. The Ministry’s SPI initiative backs our industry, providing Rs. 500 crore ($60.9 million) to strengthen productivity, quality, and sustainability across pharma clusters and MSMEs. Over the years, CPHI & P-MEC India has grown from a trade show into a global platform for business and industry insights”.

Knowledge Exchange

The CPHI & PMEC India Expo will feature The Pharma Connect Congress. This two-day event will spotlight key topics. These include “Continuous Innovation and Agile Manufacturing for Next-Generation Therapeutics.” They also cover “India as the Pharmacy of the World with Cost-Effective Generics and Biosimilars.”

Other discussions will tackle challenges in digital transformation, complexities in biosimilar manufacturing, and advances in research on biosimilars.

Additionally, the Pharma Leaders Roundtable will provide a closed-door forum for senior industry leaders. They will discuss innovation, unmet clinical needs, and strategic solutions.

The Women in Pharma Conference will address diversity and inclusion, focusing on enhancing the role of women in the industry.

As per the press release, celebrating the achievements of pharmaceutical brands, the 10th edition of the India Pharma Awards will honour exceptional contributions to the sector.